ArchiMed’s $1.2bn private equity deal with Natus Medical was the Medical devices industry’s biggest deal of Q2 2022 as deals worth $12.2bn were announced globally in the quarter, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 32% over the previous quarter and a drop of 69.3% when compared with the last four-quarter average of $39.55bn.
In terms of number of deals, the sector saw a drop of 11.49% with 539 deals in Q2 2022 against the average of 609.00 deals in the last four-quarters.
In value terms, North America led the activity with deals worth $5.39bn.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMedical devices industry deals in Q2 2022: Top deals
The top five Medical devices industry deals accounted for 33.5% of the overall value during Q2 2022.
The combined value of the top five deals stood at $4.07bn, against the overall value of $12.2bn recorded for the quarter.
The top five Medical devices industry deals of Q2 2022 tracked by GlobalData were:
1) ArchiMed $1.2bn private equity deal with Natus Medical
2) The $1bn acquisition of MediFox DAN Group by ResMed
3) EQT IX Fund $797.86m private equity deal with SPT Labtech
4) The $541.63m acquisition of Phenox by Wallaby Medical
5) Fleury $534.27m acquisition deal with Instituto Hermes Pardini
